Delivery Order SPE2DB22D1202-SPE2DB25FUTB3

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.58, is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm inhalers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,373.22, is for the delivery of fluticasone propionate HFA 220 mcg inhalers, with a final completion date of June 12, 2024. The contract is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,816,295 units of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $1,823.85 and a period of performance through January 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of fluticasone propionate HFA 110 mcg 12 gram inhalers. The $3,227.09 firm fixed price contract has an ultimate completion date of July 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,977.92, is for the delivery of fluticasone propionate HFA 110 MCG 12GM inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone propionate HFA 110 mcg inhaler units. The contract has a firm fixed price of $1,764.05 and an ultimate completion date of August 21, 2024. It is not designated as a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $9,584.41 and runs through September 5, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,561.98 firm fixed-price contract is for the supply of fluticasone propionate HFA 110 mcg inhalers. It is associated with a larger Indefinite Delivery Contract valued at $999,999,999 with DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,228,975 units of Fluticasone Propionate HFA 44 mcg 10.6 gm inhalers. The contract has a firm fixed price of $1,877.04 and runs until July 24, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Fluticasone Propionate HFA 110 MCG 12GM inhalers. The contract has a firm fixed price and a ceiling value of $9,338.45. There is no set-aside designation for this award. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUTB3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,529.30, is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:34 PM